Cargando…
Pharmacological and dietary prevention for colorectal cancer
BACKGROUND: Colorectal cancer (CRC) is a leading cause of cancer morbidity and mortality. People at higher risk are those individuals with a family history of CRC and familial adenomatous polyposis. Prevention and screening are two milestones for this disease. The aim of this study is to evaluate th...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851139/ https://www.ncbi.nlm.nih.gov/pubmed/24267792 http://dx.doi.org/10.1186/1471-2482-13-S2-S16 |
_version_ | 1782294233206489088 |
---|---|
author | Nolfo, Francesca Rametta, Stefania Marventano, Stefano Grosso, Giuseppe Mistretta, Antonio Drago, Filippo Gangi, Santi Basile, Francesco Biondi, Antonio |
author_facet | Nolfo, Francesca Rametta, Stefania Marventano, Stefano Grosso, Giuseppe Mistretta, Antonio Drago, Filippo Gangi, Santi Basile, Francesco Biondi, Antonio |
author_sort | Nolfo, Francesca |
collection | PubMed |
description | BACKGROUND: Colorectal cancer (CRC) is a leading cause of cancer morbidity and mortality. People at higher risk are those individuals with a family history of CRC and familial adenomatous polyposis. Prevention and screening are two milestones for this disease. The aim of this study is to evaluate the chemopreventive role of non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin and cyclooxygenase 2 inhibitors, some micronutrients (folic acid, calcium, selenium, antioxidants) and probiotics. DISCUSSION: The studies on aspiring reported promising results, but it is debatable whether aspirin should be used as chemoprevention, because of its side effects and because of poor efficacy evident in subjects at high risk. Similar results were reported for other non-aspirin NSAIDs, such as sulindac and celecoxib, which the potential adverse effects limit their use. Selenium role in prevention of various types of cancer as well as in colon adenomas are often inconclusive or controversial. Several studies suggested that calcium may have a possible chemopreventive effect on colon adenomas and CRC, although contrasting results are reported for the latter. A recent meta-analysis including 13 randomized trial suggested that folic acid supplementation had not a chemiopreventive action on CRC. Several studies investigated the association between antioxidants, administered alone or in combination, and CRC risk, both among general and at risk population, but only few of them supported statistically significant results. CONCLUSION: The results of this literature review showed an unclear role in CRC prevention of both pharmacological and dietary intervention. Despite several options are available to prevent colon cancer, it is challenging to identify a correct strategy to prevent CRC through pharmacological and dietary intervention due to the long latency of cancer promotion and development. Since some of the drugs investigated may have uncertain individual effects, it can be suggested to potentiate such effects by adding them together. |
format | Online Article Text |
id | pubmed-3851139 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-38511392013-12-13 Pharmacological and dietary prevention for colorectal cancer Nolfo, Francesca Rametta, Stefania Marventano, Stefano Grosso, Giuseppe Mistretta, Antonio Drago, Filippo Gangi, Santi Basile, Francesco Biondi, Antonio BMC Surg Research Article BACKGROUND: Colorectal cancer (CRC) is a leading cause of cancer morbidity and mortality. People at higher risk are those individuals with a family history of CRC and familial adenomatous polyposis. Prevention and screening are two milestones for this disease. The aim of this study is to evaluate the chemopreventive role of non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin and cyclooxygenase 2 inhibitors, some micronutrients (folic acid, calcium, selenium, antioxidants) and probiotics. DISCUSSION: The studies on aspiring reported promising results, but it is debatable whether aspirin should be used as chemoprevention, because of its side effects and because of poor efficacy evident in subjects at high risk. Similar results were reported for other non-aspirin NSAIDs, such as sulindac and celecoxib, which the potential adverse effects limit their use. Selenium role in prevention of various types of cancer as well as in colon adenomas are often inconclusive or controversial. Several studies suggested that calcium may have a possible chemopreventive effect on colon adenomas and CRC, although contrasting results are reported for the latter. A recent meta-analysis including 13 randomized trial suggested that folic acid supplementation had not a chemiopreventive action on CRC. Several studies investigated the association between antioxidants, administered alone or in combination, and CRC risk, both among general and at risk population, but only few of them supported statistically significant results. CONCLUSION: The results of this literature review showed an unclear role in CRC prevention of both pharmacological and dietary intervention. Despite several options are available to prevent colon cancer, it is challenging to identify a correct strategy to prevent CRC through pharmacological and dietary intervention due to the long latency of cancer promotion and development. Since some of the drugs investigated may have uncertain individual effects, it can be suggested to potentiate such effects by adding them together. BioMed Central 2013-10-08 /pmc/articles/PMC3851139/ /pubmed/24267792 http://dx.doi.org/10.1186/1471-2482-13-S2-S16 Text en Copyright © 2013 Nolfo et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Nolfo, Francesca Rametta, Stefania Marventano, Stefano Grosso, Giuseppe Mistretta, Antonio Drago, Filippo Gangi, Santi Basile, Francesco Biondi, Antonio Pharmacological and dietary prevention for colorectal cancer |
title | Pharmacological and dietary prevention for colorectal cancer |
title_full | Pharmacological and dietary prevention for colorectal cancer |
title_fullStr | Pharmacological and dietary prevention for colorectal cancer |
title_full_unstemmed | Pharmacological and dietary prevention for colorectal cancer |
title_short | Pharmacological and dietary prevention for colorectal cancer |
title_sort | pharmacological and dietary prevention for colorectal cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851139/ https://www.ncbi.nlm.nih.gov/pubmed/24267792 http://dx.doi.org/10.1186/1471-2482-13-S2-S16 |
work_keys_str_mv | AT nolfofrancesca pharmacologicalanddietarypreventionforcolorectalcancer AT ramettastefania pharmacologicalanddietarypreventionforcolorectalcancer AT marventanostefano pharmacologicalanddietarypreventionforcolorectalcancer AT grossogiuseppe pharmacologicalanddietarypreventionforcolorectalcancer AT mistrettaantonio pharmacologicalanddietarypreventionforcolorectalcancer AT dragofilippo pharmacologicalanddietarypreventionforcolorectalcancer AT gangisanti pharmacologicalanddietarypreventionforcolorectalcancer AT basilefrancesco pharmacologicalanddietarypreventionforcolorectalcancer AT biondiantonio pharmacologicalanddietarypreventionforcolorectalcancer |